The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term survival for some patients with stage-IV cancers while maintaining their quality of life. The study is published in the January issue of International Journal of Radiation Oncology • Biology • Physics (Red Journal).
January 31, 2019 
News | Ultrasound Imaging
Konica Minolta Healthcare Americas Inc. released a new software upgrade for the Sonimage HS1 Ultrasound System that delivers workflow improvements, new imaging capabilities and artificial intelligence-assisted functionality for hands-free operation during interventional procedures. Designed with the musculoskeletal (MSK) practitioner in mind, the HS1 System features advanced functionality to support confident diagnoses and treatment management at the point of care.
January 31, 2019 
News | Treatment Planning
January 31, 2019 — Philips announced a collaboration with imaging solutions provider MIM Software Inc. to improve ...
January 31, 2019 Sponsored Content
Sponsored Content
Videos | Radiology Business
Radiology departments have many different needs and face a wide variety of challenges that can impact their departments ...
November 11, 2025 
News | Artificial Intelligence
January 30, 2019 – The Radiological Society of North America (RSNA) published the first issue of its new online journal ...
January 30, 2019 
January 30, 2019 — Magnetic resonance imaging (MRI) provides a safe, noninvasive way to monitor liver fat levels in ...
January 30, 2019 
News | Ultrasound Women's Health
January 30, 2019 — QTbreasthealth launched a center in Grand Rapids, Mich., featuring its quantitative transmission ...
January 30, 2019 Sponsored Content
Feature | Breast Imaging
Despite decades of progress in breast imaging, one challenge continues to test even the most skilled radiologists ...
October 24, 2025 
ImaginAb Inc. announced the enrollment of the first patient in the Phase II clinical trial of the company’s CD8+ T Cell imaging agent. The trial will enroll metastatic cancer patients and will study the correlation of imaging signals observed using ImaginAb’s CD8+ T cell ImmunoPET imaging agent, standard-of-care scans and immunohistochemistry analysis of CD8 in biopsied tissues.
January 30, 2019 
Blog | Artificial Intelligence
The odds are good that radiologists want to believe in artificial intelligence (AI). The hype from vendors, professional ...
January 30, 2019 
Feature | Breast Imaging | By Jeff Zagoudis
The importance of early detection of breast cancer has been underscored in recent years as the breast health community ...
January 30, 2019 Sponsored Content
Sponsored Content
Videos | Radiology Business
Bayer Radiology’s Barbara Ruhland and Thom Kinst discuss how radiology departments can address the many different ...
October 09, 2025 
Technology | Magnetic Resonance Imaging (MRI)
January 30, 2019 — The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Lumina 3 Tesla (3T) magnetic ...
January 30, 2019 
Feature | Radiation Oncology | By Dave Fornell
Artificial intelligence (AI) has been the hot topic discussed at all trade shows, and the 2018 American Society for ...
January 30, 2019 
Sponsored Content | Case Study | Contrast Media
The medical imaging market relies heavily on contrast media, injected into patients to increase the contrast of bodily ...
January 30, 2019 Sponsored Content
Case Study | PACS
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
February 03, 2025 
Videos | Lung Imaging
Gregory Videtic, M.D., staff physician in radiation oncology at the Cleveland Clinic, and David Johnstone, M.D ...
January 29, 2019 
Technology | Remote Viewing Systems
EBM Technologies announced that its vendor-neutral, remote reading system Rad@ has been granted Class II U.S. Food and Drug Administration (FDA) clearance for diagnostic reading of radiological images. The system can benefit radiologists by untethering them from traditional fixed workstations and paving the way for greater work flexibility and financial efficiencies. With Rad@, radiologists can now interpret images and make diagnosis independent of their location.
January 29, 2019 
News | Computed Tomography (CT)
MaxQ AI and GE Healthcare announced that MaxQ's Accipio artificial intelligence (AI) platform will now be a part of GE Healthcare's Computed Tomography (CT) Smart Subscription offering. GE Healthcare's Smart Subscription provides customers with continuous access to the latest imaging software updates, through an available automatic download to their CT scanners from the cloud. As a Smart Subscription offering, hospitals with GE Healthcare CTs can easily and seamlessly integrate MaxQ's Accipio platform, from which Accipio Ix intracranial hemorrhage (ICH) detection software is now available.
January 29, 2019 
Feature | Digital Radiography (DR) | By Jeff Zagoudis
X-rays were the first medical imaging technology to be invented, and they remain one of the most commonly performed ...
January 29, 2019 
Feature | Artificial Intelligence | By Greg Freiherr
Artificial intelligence (AI) sizzled at the Radiological Society of North America’s (RSNA) 2018 meeting as vendors ...
January 29, 2019 
Blog | Artificial Intelligence
The Radiological Society of North America’s (RSNA) 2018 conference continued its theme of artificial intelligence (AI) ...
January 29, 2019 
Feature | Vendor Neutral Archive (VNA) | By Jeff Zagoudis
As healthcare technology continues to evolve at a rapid pace, the amount of patient data being collected continues to ...
January 29, 2019 © Copyright Wainscot Media. All Rights Reserved.
Subscribe Now